Tofacitinib
2 Inquiries
477600-75-2
Pharmaceutical Grade
99%
shanghai
RUNYAN
1G,10G,100G,1KG,5KG/plastic tube packaging
2024-10-16
Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Tofacitinib
Other Name:1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-;3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;CP 690550;Tofacitinib;2097815-04-6
CAS No.:477600-75-2
Molecular Formula:C16H20N6O
InChIKeys:InChIKey=UJLAWZDWDVHWOW-YPMHNXCESA-N
Molecular Weight:312.3696
Exact Mass:312.37
EC Number:1806241-263-5
UNII:87LA6FU830
DSSTox ID:DTXSID90197271
NCI Thesaurus Code:C95800
Color/Form:Yellow foam
ATC Code:L04AA29|L - Antineoplastic and immunomodulating agents
HScode:29335990
Categories:
Characteristics-
PSA:
88.9
XLogP3:1.5
Density:1.3±0.1 g/cm3
Melting Point:White crystalline solid. MP: 199-206 °C /Tofacitinib monocitrate/
Boiling Point:585.845ºC at 760 mmHg
Flash Point:308.1±30.1 °C
Refractive Index:1.646
Water Solubility:In water, 155.1 mg/L at 25 deg C (est)
Storage Conditions:Keep container tightly closed in a dry and well-ventilated place. /Tofacitinib citrate/
Vapor Pressure:1.32X10-10 mm Hg at 25 deg C (est)
Specific rotation:Specific optical rotation: +10.4 deg at 25 °C/D (c = 0.64 in methanol)
Henrys Law Constant:Henry's Law constant = 3.17X10-21 atm-cu m/mol at 25 °C (est)
Dissociation Constants:pKa1 = 8.46 (cyano); pKa2 = 13.56 (secondary amine)
Experimental Properties:Hydroxyl radical reaction rate constant = 2.57X10-10 cu cm/molec-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H311 Toxic in contact with skin
H315 Causes skin irritation
H319 Causes serious eye irritation
H331 Toxic if inhaled
H335 May cause respiratory irritation
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide
-
Location:
Room 530, 5F, building 10, Xintiandi business center, Gongshu District, Hangzhou City, Zhejiang
-
Payment Terms:
100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2022
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
United States
tofacitinib Factory Price 99% pure CAS 477600-75-2 tofacitinib powder
100 G Aug 6, 2023 
Canada
Tofacitinib
10 G Nov 28, 2025 Post an enquiry for this product
